The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     Gautam Jayram Honoraria - AstraZeneca; Ferring; Janssen; Merck Consulting or Advisory Role - Cardinal Health; Ferring; ImmunityBio; Merck; UroGen pharma Speakers' Bureau - Ferring; ImmunityBio; Janssen; Merck Research Funding - Ferring; ImmunityBio; Merck; Protara Therapeutics   Neal Shore Stock and Other Ownership Interests - Photocure Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; ImmunityBio; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Nusano; Pfizer; Photocure; PlatformQ Health; Promaxo; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow   Leslie Aguilar Employment - TYRA Biosciences   Timothy Burn Employment - Tyra Biosciences Stock and Other Ownership Interests - Tyra Biosciences Patents, Royalties, Other Intellectual Property - Incyte; Tyra Biosciences   Christine Lihou Employment - Tyra Biosciences Stock and Other Ownership Interests - Tyra Biosciences   Viraj Degaonkar Employment - Genentech; Tyra Biosciences Stock and Other Ownership Interests - Genentech; Tyra Biosciences Patents, Royalties, Other Intellectual Property - Genentech   Erik Goluboff Employment - Tyra Biosciences Stock and Other Ownership Interests - Tyra Biosciences Honoraria - Tyra Biosciences Research Funding - Tyra Biosciences   Dinesh Ganapathy Employment - Ferring; Tyra Biosciences Stock and Other Ownership Interests - Tyra Biosciences   Seth Lerner Stock and Other Ownership Interests - Aura Biosciences; C2i genomics Honoraria - Grand Rounds in Urology; UroToday Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Bristol-Myers Squibb Foundation/Janssen; Ferring; Gilead Sciences; ImmunityBio; Protara Therapeutics; SURGE Therapeutics; Trigone Pharma; Urogen pharma; Vaxiion; Verity Pharmaceuticals Research Funding - Aura Biosciences; FKD Therapies; Japan BCG Laboratory; QED Therapeutics; Roche/Genentech; SURGE Therapeutics; Vaxiion Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier Other Relationship - Bladder Cancer Journal; UpToDate